Search results for #JIPO
@aysunsenturk Great photo of Editor in Chief @ANaingMD and Editorial Fellow @aysunsenturk at the Turkish Society of Radiation Oncology Symposium! #TROD #RadiationOncology #JIPO
Be the first to know about new issues, community events, and industry developments in #precisiononcology when you subscribe to #JIPO! #oncology #immunotherapy tinyurl.com/2jp49b7f
#JIPO review by Torres et al. explores the management of HepB & HepC in patients w cancer receiving ICIs Read the article: doi.org/10.36401/JIPO-… Watch the interview: loom.ly/3-oaAjM #cancer #hepatitisB #hepatitisC
こういう連中こそ真っ先に取り締まる必要があるんだが…権力者と称する事実上の職業犯罪者のやる事は万国共通か…: EUの閣僚が児童性的虐待規制案から警察官・軍人・諜報員に加えEU閣僚である自分自身を除外するよう要請 - GIGAZINE gigazine.net/news/20240419-… #seiji #senkyo #kisei #jipo #hijitsuzai
Review by Falchook et al. discusses clinical trials related to T-cell immunoglobulin & mucin domain containing TIM-3 inhibitors doi.org/10.36401/JIPO-… #JIPO #TIM3inhibitor #clinicaltrials #cancer
どう見ても悪用前提っつーか表現弾圧に繋げようとしてるとしか: 同意なしの性的なディープフェイク画像作成を禁止する法案がイギリスで提出される、作成者に画像共有の意図があるかどうかは関係なし - GIGAZINE gigazine.net/news/20240417-… #seiji #senkyo #kisei #jipo #hijitsuzai
宗教=カルトが生成AIを表現弾圧の口実にして、それに政治・行政も危険性を承知の上で乗っかろうとしてんのか…。: ASCII. jp:画像生成AI“児童ポルノ”学習問題、日本では表現規制の議論にも ascii.jp/elem/000/004/1… #seiji #senkyo #kisei #jipo #hijitsuzai
醜悪ルールっつーか検閲そのものなんだが…: 尻の突き出しは禁止、TバックはOK…? 公営プールでの水着撮影会、なぜ醜悪ルールまでつくって認めるのか:東京新聞 TOKYO Web tokyo-np.co.jp/article/321107 #seiji #senkyo #kisei #jipo #hijitsuzai
Review the abstracts presented at the 2023 Emirates Oncology Conference #EOC doi.org/10.36401/JIPO-… #JIPO #cancertreatment #oncology #immunotherapy
#JIPO case report studies the response of nresectable sinonasal NUT carcinoma when treated with immunotherapy & BET inhibitors, by Herbison et al. doi.org/10.36401/JIPO-… #immunotherapy #BETinhibitors #carcinoma
New case study by Khalid Jazieh et al. "Keeping an Eye Out for Immunotherapy Toxicity..." doi.org/10.36401/JIPO-… @kjazieh #immunotherapy #JIPO #Ipilimumab #Nivolumab
#JIPO research article by Ebinama et al. assesses the risk of developing pulmonary irAEs w/ exposure to 5 commonly used ICIs: nivolumab, pembrolizumab, durvalumab, avelumab, & atezolizumab doi.org/10.36401/JIPO-… #Oncology #AdverseEvents
This review by Ser et al. discusses the outcomes of clinical trials employing immune checkpoint inhibitors (ICIs) in patients with #glioblastoma and reviews ICI combination strategies doi.org/10.36401/JIPO-… #immunotherapy #inhibitors #JIPO
#JIPO review investigates prescence of common oral toxicities & their reactions w #ICIs, by Srivastava et al. Article: doi.org/10.36401/JIPO-… Interview: loom.ly/kz_6Spc #immunotherapy #inhibitors @aysunsenturk